The National Institute for Health and Care Excellence (NICE) in the UK has now approved rTMS
(Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK.
The guidelines issued by NICE have not specified or restricted the type of rTMS treatment, which means that practitioners can offer treatment using conventional rTMS – which takes around 40 minutes per session – and/or theta burst, which takes around 5 minutes.
Repetitive Transcranial Magnetic Stimulation is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood.
The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants.
rTMS has also been shown effective in treating migraine, post-natal depression and pain
Ectron are the UK exclusive distributors of Magventure's rTMS system known as Magvita . This is the only system that has been awarded a CE mark for clinical use.
rTMS treatment is now available from SmartTMS
read more about the approval at: NICE GUIDELINES
Timing and the 10 Years Tyromotion Celebration
Over the next few days the team from Ectron will be in Graz celebrating 10 years of Tyromotion with the Tyromotion team and their international partners. During the event Ectron will learn about the latest advances in Tyromotion technology.
In addition to Kathryn Farris, Tyromotion are introducing two more guest speakers.
Dr. Andrea Turolla, PT PhD
IRCCS San Camillo Hospital Foundation – Venice/Italy
Topic: New approaches for closed-loop control of devices, in rehabilitation: principles and evidence.
Michael Laborn, OT
Ergotherapie Laborn – Ergoldsbach/Bavaria/Germany
Topic: Computer aided intensive therapy of the hand- and arm-function. A promising approach.
To keep up to all the latest news from the event please follow Ectron on twitter
The popular TMS Course held at Maastricht University is for the first time offered in London tailored at a UK audience. The course is designed for health care professionals working with TMS, or considering working with TMS, clinicians and researchers who seek training in transcranial magnetic stimulation. The course consists of a mix of academic sessions and hands-on sessions.
The Clinical TMS Certification Course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The Clinical TMS Certification Course is provided by academics and specialists from Maastricht University and was granted 11 European CME credits (ECMEC) by the EACCME.
European Accreditation is granted by the EACCME in order to allow participants who attend the above-mentioned activity to validate their credits in their own country.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
The 'Clinical TMS Certification Course' is designated for a maximum of (or 'for up to') 11 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.